E-AB-10579
RETNLB Polyclonal Antibody
Size
£106.20
Was £118.00
- SKU:
- E-AB-10579
- Additional Names:
- C/EBP epsilon regulated myeloid specific secreted cysteine rich protein precursor 2,CCGR,Colon and small intestine specific cysteine rich protein,Colon and small intestine-specific cysteine-rich protein,Colon carcinoma,Colon carcinoma related gene protein
- Application:
- IHC
- Concentration:
- 0.3 mg/ml
- Purification:
- Affinity Purified
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles.
- Supplier:
- Elabscience
- Host:
- Rabbit
- Reactivities:
- Human
- Buffer:
- Phosphate buffered solution, pH 7.4, containing 0.05% stabilizer and 50% glycerol.
- Immunogen:
- Recombinant protein of human RETNLB
- Uniprot:
- Q9BQ08
- Synonyms:
- C/EBP-epsilon regulated myeloid-specific secreted cysteine-rich protein precursor 2;colon and small intestine-specific cysteine-rich protein;colon carcinoma-related gene protein;cysteine-rich secreted A12-alpha-like protein 1;cysteine-rich secreted protein A12-alpha-like 1;cysteine-rich secreted protein FIZZ2;FIZZ1;FIZZ2;found in inflammatory zone 1;HXCP2;RELM-beta;RELMb;RELMbeta;resistin-like beta;XCP2
- Extra Details:
- Resistin-like betais aproteinthat in humans is encoded by theRETNLBgene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.
- Shipping Conditions:
- Blue Ice